Form 4: P&G Health Care CEO Sells Shares for Tax Cover
Insider Transaction Report
Procter & Gamble's CEO of Health Care, Jennifer L. Davis, sold 8,596 shares of common stock to cover taxes on a stock award.
Summary
- Jennifer L. Davis, CEO of Health Care at Procter & Gamble Co (PG), sold 8,596 shares of common stock.
- The transaction occurred on August 19, 2025, at a price of $157.2738 per share.
- The sale was explicitly stated to cover taxes on a stock award.
- Following the transaction, Jennifer L. Davis directly owns 64,990.9326 shares and indirectly owns 15,401.6828 shares through a retirement plan trustee.
Sentiment
Score: 5
Explanation: The transaction is neutral. It's a routine sale to cover taxes on a stock award, which is a common practice for executives receiving equity compensation and does not indicate a change in company fundamentals or executive confidence.
Positives
- The sale was for a specific, common, and non-discretionary reason (tax coverage), not indicative of a lack of confidence in the company.
Negatives
- A reduction in direct beneficial ownership by a key executive, even if for tax purposes.
Future Outlook
NA
Industry Context
This Form 4 filing details an individual executive's stock transaction and does not provide broader industry context or trends. The transaction is specific to Jennifer L. Davis's personal financial management related to her compensation at Procter & Gamble.
Stakeholder Impact
- Shareholders: Minimal direct impact. A small reduction in insider ownership, but for a non-discretionary reason.
- Employees, Customers, Suppliers, Creditors: No direct impact from this specific insider transaction.
Key Dates
| Date | Description |
|---|---|
| 08/19/2025 | Date of earliest transaction (sale of common stock). |
| 08/21/2025 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThe filing details a routine insider stock sale by an executive to cover taxes on a stock award. This type of transaction is common and does not typically signal a change in the company's fundamental outlook or the executive's confidence. Therefore, it provides no new information that would warrant a change in investment recommendation for Procter & Gamble shares.
Keywords
Procter & Gamble, PG, Insider Trading, Form 4, Stock Sale, Executive Compensation, Jennifer L. Davis, Health Care CEO, Tax Cover
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.